PROCTER & GAMBLE HEALTH | AARTI DRUGS | PROCTER & GAMBLE HEALTH/ AARTI DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 25.7 | 134.8% | View Chart |
P/BV | x | 10.6 | 3.9 | 271.7% | View Chart |
Dividend Yield | % | 2.0 | 0.2 | 1,013.0% |
PROCTER & GAMBLE HEALTH AARTI DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
AARTI DRUGS Mar-23 |
PROCTER & GAMBLE HEALTH/ AARTI DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 532 | 1,009.3% | |
Low | Rs | 3,883 | 311 | 1,249.4% | |
Sales per share (Unadj.) | Rs | 740.7 | 293.3 | 252.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 18.0 | 769.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 23.4 | 663.1% | |
Dividends per share (Unadj.) | Rs | 95.00 | 1.00 | 9,500.0% | |
Avg Dividend yield | % | 2.1 | 0.2 | 865.3% | |
Book value per share (Unadj.) | Rs | 447.6 | 128.8 | 347.6% | |
Shares outstanding (eoy) | m | 16.60 | 92.60 | 17.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.4 | 434.7% | |
Avg P/E ratio | x | 33.5 | 23.4 | 142.7% | |
P/CF ratio (eoy) | x | 29.8 | 18.0 | 165.6% | |
Price / Book Value ratio | x | 10.3 | 3.3 | 315.8% | |
Dividend payout | % | 68.7 | 5.6 | 1,234.6% | |
Avg Mkt Cap | Rs m | 76,761 | 39,003 | 196.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 804 | 256.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 27,161 | 45.3% | |
Other income | Rs m | 184 | 22 | 838.2% | |
Total revenues | Rs m | 12,480 | 27,182 | 45.9% | |
Gross profit | Rs m | 3,247 | 3,095 | 104.9% | |
Depreciation | Rs m | 281 | 503 | 55.8% | |
Interest | Rs m | 8 | 371 | 2.1% | |
Profit before tax | Rs m | 3,142 | 2,242 | 140.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 578 | 146.5% | |
Profit after tax | Rs m | 2,295 | 1,664 | 137.9% | |
Gross profit margin | % | 26.4 | 11.4 | 231.8% | |
Effective tax rate | % | 27.0 | 25.8 | 104.5% | |
Net profit margin | % | 18.7 | 6.1 | 304.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 14,923 | 78.5% | |
Current liabilities | Rs m | 6,791 | 9,330 | 72.8% | |
Net working cap to sales | % | 40.0 | 20.6 | 194.4% | |
Current ratio | x | 1.7 | 1.6 | 107.8% | |
Inventory Days | Days | 263 | 6 | 4,603.9% | |
Debtors Days | Days | 343 | 1,162 | 29.6% | |
Net fixed assets | Rs m | 10,617 | 9,290 | 114.3% | |
Share capital | Rs m | 166 | 926 | 17.9% | |
"Free" reserves | Rs m | 7,265 | 10,998 | 66.1% | |
Net worth | Rs m | 7,431 | 11,924 | 62.3% | |
Long term debt | Rs m | 0 | 2,047 | 0.0% | |
Total assets | Rs m | 22,330 | 24,214 | 92.2% | |
Interest coverage | x | 409.1 | 7.0 | 5,813.3% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.1 | 49.1% | |
Return on assets | % | 10.3 | 8.4 | 122.7% | |
Return on equity | % | 30.9 | 14.0 | 221.4% | |
Return on capital | % | 42.4 | 18.7 | 226.6% | |
Exports to sales | % | 0 | 31.4 | 0.0% | |
Imports to sales | % | 13.1 | 33.4 | 39.0% | |
Exports (fob) | Rs m | NA | 8,536 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 9,082 | 17.7% | |
Fx inflow | Rs m | 1,465 | 8,536 | 17.2% | |
Fx outflow | Rs m | 1,605 | 9,352 | 17.2% | |
Net fx | Rs m | -140 | -816 | 17.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 1,342 | 175.9% | |
From Investments | Rs m | -215 | -1,640 | 13.1% | |
From Financial Activity | Rs m | -985 | 165 | -595.3% | |
Net Cashflow | Rs m | 1,160 | -132 | -877.1% |
Indian Promoters | % | 0.0 | 57.1 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 8.6 | 233.6% | |
FIIs | % | 6.2 | 2.6 | 243.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 42.9 | 112.4% | |
Shareholders | 56,778 | 157,547 | 36.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | AARTI DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.59% | 0.45% |
1-Month | -1.15% | 13.61% | 2.55% |
1-Year | 0.73% | 21.62% | 56.14% |
3-Year CAGR | -8.76% | -11.15% | 15.22% |
5-Year CAGR | 4.97% | 26.46% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the AARTI DRUGS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of AARTI DRUGS the stake stands at 57.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of AARTI DRUGS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
AARTI DRUGS paid Rs 1.0, and its dividend payout ratio stood at 5.6%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of AARTI DRUGS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.